Sidley represented Star51 Capital in connection with its investment in UltraSight™, a leader in AI-guided cardiac workflows, as part of the company’s US$24 million Series B2 financing. The financing was led by Alive HealthTech Growth Fund, with additional participation from Deep Insight, Connecticut Innovations, and eHealth Ventures, as well as existing investors Mayo Clinic Ventures, New York University, and Iron Nation. UltraSight™ intends to use the proceeds to support its U.S. commercial expansion, develop new workflows for intensive care and circulatory support settings, and pursue strategic collaborations to expand adoption of its Echosystem platform.
The Sidley team was led by Mayan Katz (Emerging Companies and Venture Capital).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
